Urgo Medical’s UrgoStart is a wound dressing that combines technology lipido-colloid (TLC) and nano-oligo saccharide factor (NOSF) to promote wound healing.

The TLC-NOSF technology helps promote granulation of chronic wounds. The TLC forms a moist environment that promotes the healing process so that key cells in the repair process can begin healing. NOSF forms a gel that binds preferentially to damaged areas and limited the harmful action of Matrix Metalloprotienases, according to the company.

Australia-based Urgo Medical said UrgoStart is ideal for treating leg ulcers, diabetic foot ulcers and pressure ulcers.

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS